THE World Health Organization has reiterated its warning that there is a serious lack of new antibiotics under development to combat the growing threat of antimicrobial resistance, in an alarming BMJ article.
Only eight of the 51 new antibiotics and biologicals in clinical development to treat antibiotic resistant pathogens are innovative treatments that could add value to the current drugs on offer, with most of the drugs in the clinical pipeline simply modifications of existing classes of antibiotics representing only short term solutions, WHO said - bmj.com.
The above article was sent to subscribers in Pharmacy Daily's issue from 21 Sep 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Sep 17